Advertisement

Advertisement

Articles

Cervical Disc Arthroplasty: A Movement-Sparing Surgical Option in Cervical Disc Degeneration

Teaser: 

Simon Harris, MA, MB, BChir, FRCSC,

Orthopaedic Spine Surgeon, Trillium Health Partners, Mississauga, Ontario.

CLINICAL TOOLS

Abstract: Degeneration of the cervical discs is a common problem and can cause compression of cervical nerve roots and/or the spinal cord. This in turn may lead to permanent neurological injury, disability and socioeconomical impact for the patient. Surgical management typically includes either an Anterior Cervical Decompression and Fusion (ACDF) or a Posterior Decompression with or without fusion or laminoplasty. Over the past 20 years, Cervical Disc Arthroplasty (CDA) has been an increasingly viable alternative to the “Gold Standard” ACDF, after failure of conservative management in the appropriately selected patient. Single and multilevel CDA has a growing body of evidence to support its equivalency - and even superiority - to ACDF in long-term clinical outcomes.
Key Words: Cervical degenerative disc disease; Cervical Disc Replacement; Cervical Disc Arthroplasty; Radiculopathy; Myelopathy.

Members of the College of Family Physicians of Canada may claim MAINPRO-M2 Credits for this unaccredited educational program.

www.cfpc.ca/Mainpro_M2

You can take quizzes without subscribing; however, your results will not be stored. Subscribers will have access to their quiz results for future reference.

Cervical radiculopathy symptoms include pain, paresthesia, numbness, and weakness in a recognised dermatomal and myotomal pattern.
First-line conservative treatment for cervical radiculopathy includes physiotherapy, analgesia, and non-steroidal anti-inflammatories.
Cervical disc replacement is an evidence-supported intervention for upper extremity radiculopathy that has failed conservative treatment.
Many designs of cervical disc arthroplasty are currently available for implantation in North America.
Cervical degenerative disc disease is a common radiographic finding present in both the symptomatic and asymptomatic population.
Axial neck pain, in the absence of red flag symptoms is best managed with an active physiotherapy program and pain management strategies.
Cervical disc arthroplasty is an evidence-supported surgical option to address central or foraminal cervical stenosis at the disc level.
1 or 2-level cervical disc arthroplasty has a lower re-operation rate than anterior cervical decompression and fusion.
Cervical disc arthroplasty procedure can be performed through a 4cm incision in the front of the neck.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.

Xerosis and Ichthyosis: A Brief Review

Teaser: 

Manish Toofany,1 Joseph M. Lam, MD, FRCPC,2

1 Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
2Department of Pediatrics, Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

CLINICAL TOOLS

Abstract: Xerosis is a common skin condition that becomes more prevalent with age and is a prominent feature in ichthyosis. It primarily resulting from abnormalities in the stratum corneum, influenced by factors like natural moisturizing factors, lipid synthesis, and genetic pathologic variants. The diagnosis of xerosis and ichthyosis is usually made clinically, though specific investigations may aid in the diagnosis of specific ichthyoses. Both conditions can have a considerable negative impact on the quality of life of patients. Management includes moisturization and taking preventive measures to maintain skin health and to prevent xerosis.
Key Words: xerosis, ichthyosis, stratum corneum, natural moisturizing factors.

Members of the College of Family Physicians of Canada may claim MAINPRO-M2 Credits for this unaccredited educational program.

www.cfpc.ca/Mainpro_M2

You can take quizzes without subscribing; however, your results will not be stored. Subscribers will have access to their quiz results for future reference.

Xerosis is a common condition worldwide and it is a prominent feature of both syndromic and non-syndromic ichthyoses.
Both xerosis and ichthyosis can have a considerable negative impact on the quality of life of patients.
The diagnosis of xerosis and inherited ichthyoses is based on history, clinical manifestations, associated abnormalities, and family history, but several specific investigations may aid in the diagnosis of syndromic ichthyoses.
Managing xerosis includes applying topical moisturizers with key components like lipids and humectants while proactive preventive measures are vital for preventing triggers of the condition.
Understanding and addressing triggers such as temperature, low humidity, sunlight exposure, and environmental conditions like air conditioning or heating can be essential in managing xerosis effectively.
Evaluating the overall severity of xerosis and ichthyosis may include the use of established tools like the Dermatology Life Quality Index (DLQI) and the newer Ichthyosis Scoring System (ISS) to assess their impact on patients’ quality of life.
Identifying signs such as brittle hair, neurological abnormalities, and palmoplantar keratoderma can be suggestive of syndromic ichthyoses. These indicators are valuable for recognizing these rare conditions and guiding further examination or evaluation.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.
Disclaimer: 
Disclaimer at the end of each page

Neuromodulation for the Management of Chronic Pain After Spinal Surgery

Teaser: 

Vishal Varshney MD FRCPC,1 Jill Osborn PhD, MD, FRCPC,2 Philippe Magown PhD, MD, FRCSC,3 Scott Paquette MEd, MD, FRCSC,4 Ramesh Sahjpaul MD, MSc, FRCSC,5

1Department of Anesthesia, Providence Healthcare, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada.
2Department of Anesthesia, Providence Healthcare, Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
3Department of Surgery, Section of Neurosurgery, University of Manitoba, Health Sciences Centre, Winnipeg, MB, Canada.
4Department of Anesthesia, Providence Healthcare, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
5Department of Anesthesia, Providence Healthcare, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia,  Department of Surgery, University of British Columbia, Vancouver, BC, Canada.

CLINICAL TOOLS

Abstract: Chronic neuropathic pain is associated with substantial disability and societal economic impact. Formerly called Failed Back Surgery Syndrome, and now labelled as Chronic Pain after Spinal Surgery by the ICD-11, this entity represents persistent neuropathic leg pain following structurally corrective spinal surgery, often refractory to pharmacological and interventional management,. In appropriately selected patients where medical management has been unsuccessful, the minimally invasive surgical technique of spinal cord stimulation can reduce disability and pain. Technological advances continue to improve this approach with greater success, lessened morbidity, and expanding indications.
Key Words: chronic pain after spinal surgery, failed back surgery syndrome, neuropathic pain, spinal cord stimulation, neuromodulation.

Members of the College of Family Physicians of Canada may claim MAINPRO-M2 Credits for this unaccredited educational program.

www.cfpc.ca/Mainpro_M2

You can take quizzes without subscribing; however, your results will not be stored. Subscribers will have access to their quiz results for future reference.

1. Managing chronic pain after spinal surgery is a challenging and requires combined pharmacological and interventional options.
2. Spinal cord stimulation is a modality with strong evidence to supports its efficacy in the management of patients with chronic pain after spinal surgery.
3. The workup of patients with chronic pain after spinal surgery must include multi-tier pharmacological approaches, psychological optimization, and structural spinal assessment from a multidisciplinary group of clinicians.
Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory nervous system1. Spontaneous features include burning pain and tightness with unpredictable lancinating features.
The mechanism of spinal cord stimulation involves multiple sites within the central and peripheral nervous system. SCS can influence levels of cerebrospinal fluid neurotransmitters including increases in GABA, serotonin, Substance-P, norepinephrine, acetylcholine, and adenosine, and decreases in glutamate and aspartate.
The differential target multiplexed (paresthesia-free) spinal cord stimulation programs appear superior to the older standard paresthesia-based approach.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.

Urticaria: A Brief Review

Teaser: 

Yvonne Deng,1 Amir Gohari,2 Joseph M. Lam, MD, FRCPC,3

1Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
2Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
3Department of Pediatrics, Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

CLINICAL TOOLS

Abstract: Urticaria is a common, mast cell-driven disorder that presents with transient wheals, angioedema, or both. Clinically, it is classified into acute or chronic, depending on the duration of symptoms, and further classified by the presence or absence of inducible stimuli. Although urticaria is rarely life-threatening, it can reduce quality of life and carry significant socioeconomic burden on patients. While there is no cure to the disease, the treatment algorithm for urticaria focusses on the control of symptoms with antihistamines as the mainstay of therapy and immunosuppressive/immunomodulating therapies for severe cases.
Key Words: urticaria; pediatric urticaria; angioedema; acute urticaria; chronic spontaneous urticaria.

Members of the College of Family Physicians of Canada may claim MAINPRO-M2 Credits for this unaccredited educational program.

www.cfpc.ca/Mainpro_M2

You can take quizzes without subscribing; however, your results will not be stored. Subscribers will have access to their quiz results for future reference.

Urticaria is a common pruritic condition that is divided into acute or chronic forms. It can be idiopathic or inducible by triggers that including foods, medications, infections, environmental factors, physical stimuli, and medications.
Acute and chronic urticaria are clinical diagnoses guided by a detailed history and physical examination, and diagnostic testing is not routinely indicated, unless clinical suspicion warrants exclusion of underlying causes.
Pathogenesis of urticaria involves mast cells and subsequent release of histamines and proinflammatory mediators that result in sensory nerve activation, vasodilatation, and plasma extravasation with leukocyte recruitment to lesions.
Second-generation, non-sedating H1-antihistamines are the mainstay of treatment for all types of urticaria and dosed up to fourfold to achieve adequate control.
Individual wheals typically resolve within 24 hours without leaving residual changes on the skin. If the duration of wheals is unclear, patients or clinicians can draw a line around the lesion to observe for changes or resolution
In addition to the physical stimuli in chronic inducible urticaria, other triggers of chronic urticaria include psychosocial stress, work exposures, surgical implants, and menses.
Investigations are not needed to make a diagnosis. However, a limited work-up can be considered for potential comorbidities (e.g. thyroid hormones and autoantibodies for active thyroid disease) or to exclude other diagnoses in the appropriate clinical context (e.g. skin biopsy for urticarial vasculitis).
With the exception of avoiding alcohol consumption, pseudoallergen-free or other food elimination diets should not be routinely recommended to patients for symptom control. In fact, IgE-mediated food allergy is rarely an underlying cause of urticaria.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.
Disclaimer: 
Disclaimer at the end of each page

Pediatric Psoriasis

Teaser: 

Yvonne Deng,1 Joseph M. Lam, MD, FRCPC,2

1 Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
2Department of Pediatrics, Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

CLINICAL TOOLS

Abstract: Psoriasis is a chronic inflammatory skin disease that affects up to 1.4% of children (aged <18 years) with a strong genetic predisposition and is mediated by dysregulation in the crosstalk between the innate and adaptive immune responses. It can have significant impact on quality of life for many patients. There are various subtypes of psoriasis with plaque psoriasis being the most common presentation in both adults and children. Pediatric psoriasis is primarily a clinical diagnosis. With the advent of biologics, the treatment landscape for pediatric psoriasis has shifted and encompasses diverse modalities of therapeutics, including topical and systemic treatments, as well as phototherapy.
Key Words: pediatric psoriasis, psoriasis, chronic, inflammatory, skin disease.

Members of the College of Family Physicians of Canada may claim MAINPRO-M2 Credits for this unaccredited educational program.

www.cfpc.ca/Mainpro_M2

You can take quizzes without subscribing; however, your results will not be stored. Subscribers will have access to their quiz results for future reference.

Psoriasis affects the pediatric population and is associated with negative effects on quality of life and psychological impairments.
Lesions of pediatric plaque psoriasis may be thinner, smaller, more macerated than those classically in adult and present more commonly on the scalp, face, intertriginous areas, and extremities (flexural surfaces for younger children and extensor surfaces for older children).
Psoriasis is not an isolated condition and is correlated with higher rates of myocardial infarction, diabetes mellitus, hypertension, obesity, arthritis and liver disease.
In mild to moderate cases of psoriasis, topical therapies with a short course of corticosteroids and/or vitamin D analogue are first-line. In moderate to severe cases, narrowband UVB phototherapy, systemic agents, such as methotrexate, and biologics should be considered.
Pediatric patient should be assessed for risk factors for associated comorbidities.
A history of preceding streptococcal or viral infection can be suggestive of guttate psoriasis, which is more common in children than adults.
Approach to treatment should be guided by the extent and severity of disease, which can be quantified by BSA, the PASI score and quality of life index surveys.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.
Disclaimer: 
Disclaimer at the end of each page

Hyperhidrosis: A Brief Review

Teaser: 

Mahan Maazi, MEng,1 Joseph M. Lam, MD, FRCPC,2

1 Faculty of Medicine, University of British Columbia.
2Department of Pediatrics, Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

CLINICAL TOOLS

Abstract: Hyperhidrosis (HH) is a disorder of the eccrine sweat glands causing excessive sweating. It is caused by hyperactivity of the sympathetic nervous system resulting in excessive release of acetylcholine and activation of the sweat glands. Primary essential HH is thought to have a large genetic component, while secondary HH is the result of an underlying condition or medications. HH will often cause excessive sweating in areas with a high density of eccrine sweat glands that include the palms, soles, face, head, or axillae. Diagnosis is largely based on history and physical which can help differentiate between primary and secondary HH. Hyperhidrosis can have a significant impact on quality of life. Management includes identifying and avoiding triggers, the use of topical antiperspirants, and advanced therapies in recalcitrant cases (such as tap water iontophoresis, botulinum toxin injection and surgical options).
Key Words: hyperhidrosis (HH), primary (essential) hyperhidrosis, secondary hyperhidrosis, excessive sweating, eccrine sweat gland.

Members of the College of Family Physicians of Canada may claim MAINPRO-M2 Credits for this unaccredited educational program.

www.cfpc.ca/Mainpro_M2

You can take quizzes without subscribing; however, your results will not be stored. Subscribers will have access to their quiz results for future reference.

Hyperhidrosis is common and affects about 5% of the population
A simple measure of the severity of hyperhidrosis can be done with the 4-question hyperhidrosis disease severity score
Secondary hyperhidrosis should be ruled out with a good history and physical exam
Patients who fail treatment with topical antiperspirants can be treated with tap-water iontophoresis, botulinum toxin injections, oral anticholinergics and surgical options.
Hyperhidrosis is excessive sweating that can be most commonly primary but can have secondary causes
Patients with hyperhidrosis can experience significant impairment on quality of life and this should be explored
First-line treatment consists of topical antiperspirants
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.
Disclaimer: 
Disclaimer at the end of each page

Opioid Use in Patients Undergoing Spine Surgery

Teaser: 

Eric J. Crawford MD, FRCSC,1 Ronit Kulkarni,2 Rajesh Kumar MBBS, FRCS, FCPS, FACS, FEBNS, MRCPS,3 Ted Findlay DO, CCFP, FCFP,4 Christopher J. Nielsen MD, FRCSC,5 Stephen J. Lewis MD, FRCSC,6 Robert A. Ravinsky MDCM, MPH, FRCSC,7

1 Divisions of Orthopaedic and Spine Surgery, Sunnybrook Health Sciences Centre, Toronto, ON.
2 Medical University of South Carolina, College of Medicine, Charleston, SC.
3Division of Spine Surgery, Sunnybrook Health Sciences Centre & Department of Surgery, University of Toronto, Toronto, ON.
4Calgary Chronic Pain Center at Alberta Health Services, Calgary, AB.
5Division of Orthopaedic Surgery, Toronto Western Hospital, University Health Network & Department of Surgery, University of Toronto, Toronto, ON.
6Division of Orthopaedic Surgery, Toronto Western Hospital, University Health Network & Department of Surgery, University of Toronto, Toronto, ON.
7Department of Orthopaedics and Physical Medicine, Medical University of South Carolina, Charleston, SC.

CLINICAL TOOLS

Abstract: Opioid medications have long been known for their analgesic properties and play an important role in the treatment of acute post-surgical pain. However, in recent years there has been an increase in chronic opioid therapy (COT) for painful conditions, in particular spinal disorders. These patients can have increased postoperative analgesic requirements and may be at increased risk of complications after surgery. In this evidence-based review, we provide guidance for managing opioid and analgesic medications for patients on COT from the preoperative assessment to post-surgical management including recommendations for appropriate opioid reduction.
Key Words: low back pain, surgery, opioid sparing, peri-operative pain management.

Members of the College of Family Physicians of Canada may claim MAINPRO-M2 Credits for this unaccredited educational program.

www.cfpc.ca/Mainpro_M2

You can take quizzes without subscribing; however, your results will not be stored. Subscribers will have access to their quiz results for future reference.

1. Pre-operative chronic opioid usage is associated with poorer surgical outcomes.
2. Pre-operative chronic opioid usage is associated with prolonged post-surgical opioid therapy.
3. Pre-operative opioid tapering can achieve clinical surgical outcomes comparable to an opioid-naïve group.
4. Non-pharmacological or non-narcotic medications may help reduce pre-operative opioid usage.
5. A clear plan for a post-surgical opioid taper should be prepared prior to surgery.
The OPAL trial notes that opioids for acute non-specific low back or neck pain present no significant difference to placebo for pain at 6 weeks.
Buprenorphine is commonly used as an opioid rotation pre-operatively to assist in opioid weaning.
Discontinuing opioid prescriptions should be considered if there is a lack of overall and clinically meaningful improvement in function, quality of life or pain, or lack of progress towards meeting agreed therapeutic goals.
Gabapentin in doses over 1800 mg/day is associated with 60% increased odds of opioid related death.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.

Medicine and the Humanities

Teaser: 

Michael Gordon, MD, MSc, FRCPC,

Emeritus Professor of Medicine, Member, Joint Centre for Bioethics, University of Toronto, Toronto, ON.

CLINICAL TOOLS

Abstract: In the earliest writing of stories, physicians and illnesses often played an important role. Some of the renowned scholars in the Jewish tradition, like Moses Maimonides was a philosopher, a prolific writer, and a physician. A few of the world-famous authors include: François Rabelais (1483-1553), Anton Chekhov (1860-1904), Arthur Conan Doyle (1859-1930), Oliver Sacks (1933-2015) and the contemporary Abraham Verghese (1955-), to name just a few. The connection between medicine and the humanities appears to have diminished in some domains due partially to the focus on the scientific advances in medicine and the diminished focus on the humanities, especially in higher education. This I suggest, is a problem for medicine.
Key Words: medical humanities, education, medical students.
The exposure to the humanities in the education of physicians provides an expanded framework of understanding the person beneath the patient.
Education in the humanities should be a prerequisite or even a component of a more humanistic medical education.
As part of connecting to new patients it is important to find out who they are before asking why they are in your office or hospital bed.
Explore as many ways to connect to the patient on their life’s experiences, cultures or backgrounds in order to promote a therapeutic relationship of trust.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.

Cauda Equina Syndrome: a review of all you need to know

Teaser: 

Vega-Arroyo Miguel, MD,1 Perry Dhaliwal, MD, MPH, FRCSC,2

1 Section of Neurosurgery, Department of Surgery, University of Manitoba.
2 Assistant Professor of Neurosurgery, Section of Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba.

CLINICAL TOOLS

Abstract: Cauda equina syndrome (CES) is the collection of signs and symptoms produced by severe compression of the lumbar spinal nerves that form the cauda equina. The compression can be caused by lumbar degenerative changes, intraspinal tumors, epidural hematoma, and infections. Rapid diagnosis and treatment are paramount as CES requires emergent surgical decompression. With delay, the patient could develop permanent neurological deficits including loss of lower limb sensorimotor function, bladder, bowel, and/or sexual dysfunction. Unfortunately, even with expeditious surgery, neurological improvements remain unpredictable. Failure to fully explain the possible prognoses can involve all the healthcare providers in medicolegal consequences.
Key Words:Cauda Equina Syndrome, Spine Emergency, Urinary retention, MRI scanning, Saddle Anesthesia.

Members of the College of Family Physicians of Canada may claim MAINPRO-M2 Credits for this unaccredited educational program.

www.cfpc.ca/Mainpro_M2

You can take quizzes without subscribing; however, your results will not be stored. Subscribers will have access to their quiz results for future reference.

1. Cauda Equina Syndrome results from pathologies that compress the nerves in the lumbosacral spinal canal, most commonly due to an acute lumbar disc herniation.
2. Early diagnosis is crucial and is made clinically by distinctive symptoms of saddle anesthesia, acute urinary incontinence combined with acute back and leg pain.
3. The most consistent early clinical sign of CES is urinary retention, and the prognosis is worse when present.
4. Urgent MRI is the study of choice and should be performed to confirm or rule out CES.
5. Surgery is highly recommended within 24 hours after CES is identified.
1. Cauda Equina Syndrome is caused by a large space-occupying lesion within the central canal of the lumbosacral spine, most commonly a large disc herniation. However, compression can also be caused by lumbar degenerative changes, intraspinal tumors, epidural hematoma, and infections.
2. Cauda equina syndrome generally presents with varying degrees of sensory loss and motor weakness in the lower extremities, saddle anesthesia, and bowel/bladder dysfunction (these last 2 are required to establish the diagnosis of CES).
3. The main clinical feature between differentiating Cauda Equina Syndrome vs Conus Medullaris Syndrome, is the absence of UPPER MOTOR NEURONS findings in CES).
4. About 70% of patients with cauda equina syndrome have a previous history of lower back pain and/or sciatica.
5. Although the prognosis is largely determined by the preoperative severity of neurological deficits, early surgery improves the chance of significant recovery so patients with CES require urgent surgical intervention.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.

An Ethics Journey: From Kant to Assisted Suicide

Teaser: 

Michael Gordon, MD, MSc, FRCPC,

Emeritus Professor of Medicine, Member, Joint Centre for Bioethics, University of Toronto, Toronto, ON.

CLINICAL TOOLS

Abstract: Most of us would agree with the almost trite saving that "life is a journey". Of course it is, unless it ends tragically at birth, and even then it is a very short journey. All of us can describe how we got from one stage in life to another, whether personal, family, education or career. Many journeys seem to be in an almost straight line while others meander from one place to another, changing direction and alternating goals, sometimes zigging back and forth. I have had many wonderful journeys in my life; the choice to change career aspirations from engineering to medicine, the choice to study in medicine in Scotland, the choice to focus on geriatrics and then the choice to branch out into medical ethics to add more depth to clinical medicine. The early undergraduate study of philosophy planted the seed that eventually grew into my completing a Master's in Medical Ethics; and then expanding my teaching and practice to include palliative care and end-of-life decision-making, to most recently participating in the assessment of those requesting medical assistance in dying (MAiD in Canada).
Key Words: Kant, medical ethics, MAiD, assisted suicide, medicine.
The controversy in Canada about the evolution of MAiD legislation is an example of how polar opposite views can affect the law and the citizen’s views about end-of-life options.
One of the contemporary pillars of medical ethics is autonomy.
Doctors have to describe the benefits and risks of medications in order to get the proper consent to use the prescription.
MAiD is a complex concept. It will take time until the right balance is achieved.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.